Extended use of proton pump inhibitors linked to 33% higher dementia risk, raising concerns about widely used acid reflux medications.
- Prolonged use of common acid reflux medications, proton pump inhibitors, for over 4.4 years is linked to a 33% higher risk of dementia in later life
- The study's findings add to concerns about the potential risks associated with these widely used medications
- The study doesn't establish a definitive cause-and-effect relationship
Long-term Use of Certain Acid Reflux Drugs Linked to Higher Risk of Dementia
Go to source).
Examining Acid Reflux Medication's Impact on Dementia: Study Findings
Acid reflux, which involves stomach acid escaping and reaching the esophagus, can lead to gastroesophageal reflux disease, potentially causing esophageal damage and heightening the risk of cancer. Proton pump inhibitors function by targeting enzymes responsible for stomach acid production, thereby reducing acid levels.This study adds to a growing body of research associating these drugs, used by millions of Americans, with various conditions like heart disease, stroke, and kidney disease. Prior investigations yielded mixed results regarding the link between proton pump inhibitors and dementia, with comprehensive reviews of independent studies revealing no significant connection to dementia or Alzheimer's disease.
Balancing Benefits and Risks: Acid Reflux Medication and Long-Term Use
Though the authors of the NIH-funded "Neurology" study stop short of confirming a causative relationship between these medications and dementia, they do indicate that prolonged use of such drugs could potentially pose a risk for dementia. Dementia affects about one-third of adults aged 85 and above.To mitigate these potential risks, individuals are encouraged to engage in discussions with their healthcare providers, disclosing all medications, including over-the-counter ones. This enables healthcare professionals to review the medications and discuss their rationale with patients.
The study included over 5,700 participants without dementia at the study's commencement, tracking them for approximately 5.5 years with an average age of 75. Researchers categorized participants based on the duration of medication use, and those who employed these drugs for at least 4.4 years demonstrated the highest dementia rates.
The study accounted for factors such as age, gender, race, and underlying chronic conditions, such as hypertension and diabetes. Ultimately, those who took the medication for 4.4 years or more exhibited a 33% increased risk of dementia compared to non-users. The study's evaluation of dementia risk over a prolonged medication use period provides valuable insights compared to past studies that relied on single instances of medication use and billing data for dementia diagnoses.
The American Gastroenterological Association updated its guidelines for doctors on acid-reflux prescriptions, suggesting the lowest effective dosage for individuals with severe reflux esophagitis, Barrett's esophagus, and peptic ulcers. They also recommend dietary adjustments to avoid trigger foods, refraining from eating close to bedtime, elevating the head during sleep, and weight management.
Reference:
- Long-term Use of Certain Acid Reflux Drugs Linked to Higher Risk of Dementia - (https://www.aan.com/PressRoom/Home/PressRelease/5107)
Source-Medindia